Rotavirus Vaccine Market To Grow at 12.5 % of CAGR By 2025 – Industry Size, Top Leading Companies and Forecast Research
The Global Rotavirus Vaccine Market was valued at USD XX million in 2016, and is expected to grow at a CAGR of 12.5% by 2025. This market is driven by increasing incidence of rotavirus infection among children is a major factor that drives the market, as it leads to the rise in demand for rotavirus vaccines.
For Sample Copy of this Report @ https://www.orianresearch.com/request-sample/663073 .
The market drivers for rotavirus vaccine market are its safety profile including use in HIV/AIDS patients, growing number of immunity-compromised individuals, increasing geriatric population, growing population and live births etc.
Rotavirus disease is highly contagious and it spreads easily among children due to their poor hygiene habits. The spread of rotavirus infection is a common issue in hospitals and daycare settings.
The market restraints are risks such as immune reaction, babies who have had intussusception, low healthcare expenditure in developing regions, cleanliness initiatives by NGOs and health awareness creation to eradicate the prevalence of this virus etc.
An estimated 215,000 children died of rotavirus infections in 2013, accounting for 37% of diarrhea-related deaths worldwide, 92% of which occurred in low and lower-middle income countries. Since 2009 the World Health Organization (WHO) recommends the use of rotavirus vaccines in all national immunization programs.
This review compares rotavirus vaccine (RV) introductions and vaccine coverage by region, country income status and Gavi-eligibility from 2006–2016. Gross National Income data from the World Bank and surviving infant population from United Nations Population Division was obtained for 2016.
The North America account for a significant market share due to wide use of medications and high expenditure on the health care. Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Some of the key players operating in this market include GlaxoSmithKline (GSK), Merck, and Bharat Biotech International Limited and Others.
Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/663073 .
Key Benefits of the Report:
* Global, Regional, Country, End User, and Product Type Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Product Type & End User, and competitive landscape with qualitative and quantitative information and facts
Target Audience:
* Vaccine adjuvants manufacturers and suppliers
* Academic research institutes
* Biopharmaceutical and biotechnology companies
* Research and development (R&D) companies
* Business research and consulting service providers
* Medical research laboratories
* Academic medical centers and universities
Get Direct Copy of this Report @ https://www.orianresearch.com/checkout/663073 .
Research Methodology
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.
For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.
The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Equipment Manufacturer,
* Component Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute
TABLE OF CONTENT
1 Executive Summary
2 Methodology And Market Scope
3 Rotavirus Vaccine Market — Industry Outlook
4 Rotavirus Vaccine Market Product Type Outlook
5 Rotavirus Vaccine Market End User Outlook
6 Rotavirus Vaccine Market Regional Outlook
7 Competitive Landscape
End of the report
Disclaimer
About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.